Dr. Dmitriy N. Feldman, MD
Interventional Cardiology (Interventional Cardiology Physician)
525 E 68th St, Division Of Cardiology, Starr-4
New York, NY 10065
- Medicare participating
At a glance
- Medical school
- Icahn School of Medicine at Mount Sinai (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 426
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: Icahn School of Medicine at Mount Sinai
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
NY license 230176 -
Cardiovascular Disease Physician
NY license 230176
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- New York-Presbyterian Hospital New York, NY
Medical groups
- Weill Medical College of Cornell (2,051 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 426
- Services billed
- 1,364
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Insertion of needle into vein for collection of blood sample | 197 | 139 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 171 | 157 |
| Established patient office or other outpatient visit, 30-39 minutes | 168 | 117 |
| Established patient office or other outpatient visit, 40-54 minutes | 128 | 95 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 89 | 87 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 69 | 69 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 68 | 58 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 62 | 51 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 40 | 40 |
| Injection for imaging of aorta above heart valve with review by radiologist | 34 | 34 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Rosuvastatin Calcium Other prescribers in New York, NY | 135 |
| Atorvastatin Calcium Other prescribers in New York, NY | 127 |
| Ezetimibe Other prescribers in New York, NY | 122 |
| Metoprolol Succinate Other prescribers in New York, NY | 98 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in New York, NY | 91 |
| Amlodipine Besylate Other prescribers in New York, NY | 90 |
| Losartan Potassium Other prescribers in New York, NY | 61 |
| Isosorbide Mononitrate Er (isosorbide mononitrate) Other prescribers in New York, NY | 37 |
| Carvedilol Other prescribers in New York, NY | 32 |
| Eliquis (apixaban) Other prescribers in New York, NY | 29 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 54 payments worth $15,550 in total to this clinician.
| Medtronic, Inc. | $14,136 |
|---|---|
| W. L. Gore & Associates, Inc. | $600 |
| Boston Scientific Corporation | $273 |
| Spectrawave, Inc | $206 |
| Endologix LLC | $206 |
| Shockwave Medical, Inc | $75.27 |
| Abbott Laboratories | $28.82 |
| Scpharmaceuticals Inc. | $25.80 |
| Consulting Fee | $7,288 |
|---|---|
| Travel and Lodging | $5,465 |
| Food and Beverage | $2,198 |
| Compensation for services other than consulting (speaking, faculty) | $600 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Oct 14, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $7,288 |
| Medtronic, Inc. Dec 29, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Barcelona, Spain · in-kind | $3,908 |
| W. L. Gore & Associates, Inc. May 19, 2025 | Compensation for services other than consulting (speaking, faculty) Product in Development · Devices | $600 |
| Medtronic, Inc. Sep 10, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 11, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 11, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $301 |
| Medtronic, Inc. Sep 12, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $289 |
| Medtronic, Inc. Dec 30, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Barcelona, Spain · in-kind | $100 |
| Medtronic, Inc. Oct 6, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $66.35 |
| Medtronic, Inc. Sep 10, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $51.04 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Medtronic, Inc. Dec 30, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Barcelona, Spain · in-kind | $100 |
| Medtronic, Inc. Dec 29, 2025 | Travel and Lodging SYMPLICITY G3 · Renal Denervation System · travel to Barcelona, Spain · in-kind | $3,908 |
| Medtronic, Inc. Oct 14, 2025 | Consulting Fee SYMPLICITY G3 · Renal Denervation System | $7,288 |
| Medtronic, Inc. Oct 6, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $66.35 |
| Medtronic, Inc. Sep 12, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $289 |
| Medtronic, Inc. Sep 11, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 11, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $301 |
| Medtronic, Inc. Sep 11, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $51.04 |
| Medtronic, Inc. Sep 10, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $349 |
| Medtronic, Inc. Sep 10, 2025 | Travel and Lodging travel to Weehawken, NJ · in-kind | $51.04 |
| W. L. Gore & Associates, Inc. May 19, 2025 | Compensation for services other than consulting (speaking, faculty) Product in Development · Devices | $600 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $172,453 in research payments for these studies, mostly to the institutions running them.
- SPYRAL AFFIRM
Medtronic, Inc. - A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS)
Janssen Research & Development, LLC - SPYRAL HTN-ON MED Expan
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.